(PharmaNewsWire.Com, April 20, 2017 ) According to Publisher, the Global Nephrology and Urology Devices is valued at $17.28 billion in 2015 and is expected to grow at a CAGR of 7.2% to reach $28.27 billion by 2022. Rising occurrence of chronic kidney diseases, increased spending on healthcare among the emerging regions and growing aged population across the world are some of the factors favoring the market growth. Moreover, the growing awareness about the benefits of these devices such as abridged recovery and treatment time is also propelling the global market. On the other hand, the high cost linked with these devices hampers the market.
Dialysis devices commanded the largest market share and BPH treatment devices are anticipated to witness the fastest growth during the forecast period. Fresenius was leading the market in dialysis devices followed Baxter Corporation. Benign Prostatic Hyperplasia is a major concern and is expected to affect around 75% of male over the age of 55, thus driving the market to grow. Regionally, Europe is presently leading the market owing to the increasing need to keep up with the infrastructural requirements in hospital in region. Asia-Pacific is expected to grow at a faster pace due to the promising medical tourism industry in the region. New Product launch, merger and acquisition, and research and development are the successful strategies followed by the players in the market to gain the traction.
Some of the key players in global Nephrology and Urology Devices market are Nikkiso Co. Ltd., Boston Scientific, American Medical Systems, LLC, Cook Medical, Olympus Medical Systems, Asahi Kasei Corporation, Rockwell Medical Technologies Inc., Dornier MedTech, Coloplast, Terumo Corporation, Fresenius Medical Care, B Braun Group, Nipro Corporation, Baxter International Inc., NxStage Medical, Inc. and C. R. Bard, Inc.,.
Products Covered: -Benign Prostatic Hyperplasia Devices -Urinary Stone Treatment -Prostate Cancer -Urinary Incontinence Devices -UI-Bulking -UI-Slings -Urological Endoscopes -Urological Catheters -Dialysis Devices -Erectile Dysfunction Device -Nephrostomy -Pelvic Floor Repair -Ureteral Access Devices -Endoscopy Devices Type of Diseases Covered: -Urinary Incontinence (UI) and Pelvic Organ Prolapsed (POP) -Incontinence Products -Interventional Therapies -Urinary Stone -Open Surgery -Percutaneous Nephrostolithotomy (PCNL) -Laser Lithotripsy -Extra-Corporeal Shock Wave Lithotripsy (ESWL) -Benign Prostatic Hyperplasia (BPH) -Holmium Laser Enucleation of Prostate (HOLEP) -Transurethral Radio Frequency Needle Ablation of the Prostate (TUNA) -Stenting (Prostatic Stents) -Surgery for BPH -Catheterization -Transurethral Microwave Thermotherapy of the Prostate (TUMT) -Chronic Kidney Disease And Renal Failure -Hemodialysis -Kidney Transplant -Peritoneal Dialysis End Users Covered: -Hospitals and Clinics -Ambulatory Surgical Centers (ASC) -Home -Other End Users
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -France -Italy -UK -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -Rest of Asia Pacific -Rest of the World -Middle East -Brazil -Argentina -South Africa -Egypt
10 Company Profiling 10.1 Nikkiso Co. Ltd. 10.2 Boston Scientific 10.3 American Medical Systems, LLC 10.4 Cook Medical 10.5 Olympus Medical Systems 10.6 Asahi Kasei Corporation 10.7 Rockwell Medical Technologies Inc. 10.8 Dornier MedTech 10.9 Coloplast 10.10 Terumo Corporation 10.11 Fresenius Medical Care 10.12 B Braun Group 10.13 Nipro Corporation 10.14 Baxter International Inc. 10.15 NxStage Medical, Inc. 10.16 C. R. Bard, Inc.,
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
